Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 3 result(s)

Network for the Detection of Atmospheric Composition Change

NDACC

Subject(s)
Content type(s)
Country
The Network for the Detection of Atmospheric Composition Change (NDACC), a major contributor to the worldwide atmospheric research effort, consists of a set of globally distributed research stations providing consistent, standardized, long-term measurements of atmospheric trace gases, particles, spectral UV radiation reaching the Earth's surface, and physical parameters, centered around the following priorities.

European-Mediterranean Seismological Centre

EMSC

Subject(s)
Content type(s)
Country
EMSC collects real time parametric data (source parmaters and phase pickings) provided by 65 seismological networks of the Euro-Med region. These data are provided to the EMSC either by email or via QWIDS (Quake Watch Information Distribution System, developped by ISTI). The collected data are automatically archived in a database, made available via an autoDRM, and displayed on the web site. The collected data are automatically merged to produce automatic locations which are sent to several seismological institutes in order to perform quick moment tensors determination.

Liverpool COVID-19 Drug Interactions

Subject(s)
Content type(s)
Country
The COVID-19 pandemic has affected every country in the world. It is well documented that those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and those with underlying comorbidities. Therefore, patients requiring treatment for COVID-19 will also be on additional medication, posing a risk for drug-drug interactions (DDIs). In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.